izpis_h1_title_alt

Cytotoxic activity of LLO Y406A is targeted to the plasma membrane of cancer urothelial cells
ID Resnik, Nataša (Author), ID Tratnjek, Larisa (Author), ID Erdani-Kreft, Mateja (Author), ID Kisovec, Matic (Author), ID Aden, Saša (Author), ID Bedina Zavec, Apolonija (Author), ID Anderluh, Gregor (Author), ID Podobnik, Marjetka (Author), ID Veranič, Peter (Author)

.pdfPDF - Presentation file, Download (45,19 MB)
MD5: D79667A5CCF1827ABF29F161F4BED822
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/22/7/3305 This link opens in a new window

Abstract
Identification of novel agents for bladder cancer treatment is highly desirable due to the high incidence of tumor recurrence and the risk of progression to muscle-invasive disease. The key feature of the cholesterol-dependent toxin listeriolysin O mutant (LLO Y406A) is its preferential activity at pH 5.7, which could be exploited either directly for selective targeting of cancer cells or the release of accumulated therapeutics from acidic endosomes. Therefore, our goal was to compare the cytotoxic effect of LLO Y406A on cancer cells (RT4) and normal urothelial cells (NPU), and to identify which cell membranes are the primary target of LLO Y406A by viability assays, life-cell imaging, fluorescence, and electron microscopy. LLO Y406A decreased viability, altered cell morphology, provoked membrane blebbing, and induced apoptosis in RT4 cells, while it did not affect NPU cells. LLO Y406A did not cause endosomal escape in RT4 cells, while the plasma membrane of RT4 cells was revealed as the primary target of LLO Y406A. It has been concluded that LLO Y406A has the ability to selectively eliminate cancer urothelial cells through pore-forming activity at the plasma membrane, without cytotoxic effects on normal urothelial cells. This promising selective activity merits further testing as an anti-cancer agent.

Language:English
Keywords:bladder cancer, cancer urothelial cells, normal urothelial cells, listeriolysin O, blebbing, calcium influx, pore-forming toxin, cytolysin, cytotoxicity
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:15 str.
Numbering:Vol. 22, iss. 7, art. 3305
PID:20.500.12556/RUL-135019 This link opens in a new window
UDC:577
ISSN on article:1422-0067
DOI:10.3390/ijms22073305 This link opens in a new window
COBISS.SI-ID:57572867 This link opens in a new window
Publication date in RUL:17.02.2022
Views:1067
Downloads:152
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.04.2021

Secondary language

Language:Slovenian
Keywords:biokemija, rakave celice, listeriolizin O, toksini

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0108
Name:Diferenciacija urotelijskih celic

Funder:ARRS - Slovenian Research Agency
Project number:P1-0391
Name:Molekulske interakcije

Funder:ARRS - Slovenian Research Agency
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back